Immunome Inc. (IMNM) NASDAQ
$14.27 (0.39) (-2.66%)
Market Cap: $875.12M
As of 04/24/24 04:00 PM EDT. Market closed.
Immunome Inc. (IMNM)
NASDAQ
$14.27
(0.39) (-2.66%)
Market Cap: $875.12M
As of 04/24/24 04:00 PM EDT. Market closed.
Add to Portfolio
immunome is a biotechnology company with a growing pipeline of cancer immunotherapies fueled by the human immune system. our unique and powerful immunotherapy discovery engine leverages “most highly educated” immune systems from patients who have already learned how to fight off their disease. this proprietary technology platform enables the simultaneous discovery of novel antigens and the ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Full Time Employees
49
Address
.
PRICE CHART FOR IMMUNOME INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$14.63
Previous Close
$14.66
Days Range
$14.20 - $14.92
52 week range
$4.44 - $30.96
Volume
555,483
Avg. Volume (30 days)
820,327
Market Cap
$875.12M
Dividend Yield
-
P/E
-
Shares Outstanding
59,694,243
Open
$14.63
Previous Close
$14.66
Days Range
$14.20 - $14.92
52 week range
$4.44 - $30.96
Volume
555,483
Avg. Volume (30 days)
820,327
Market Cap
$875.12M
Dividend Yield
-
P/E
-
Shares Outstanding
59,694,243
FINANCIAL STATEMENTS FOR IMMUNOME INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR IMMUNOME INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| SIEGALL CLAY B | President and CEO | Oct 02, 2023 | Buy | $5.91 | 169,204 | 999,996 | 319,636 | Oct 04, 2023, 05:35 PM |
| Turner Bruce | Chief Strategy Officer | Oct 02, 2023 | Buy | $5.91 | 42,300 | 249,993 | 42,300 | Oct 04, 2023, 05:32 PM |
| RAPP MICHAEL | Director | Oct 02, 2023 | Option Exercise | $5.91 | 253,806 | 1,499,993 | 1,071,172 | Oct 03, 2023, 05:50 PM |
| WAGENHEIM PHILIP | Director | Jan 15, 2023 | Option Exercise | $4.00 | 8,750 | 35,000 | 406,147 | Jan 17, 2023, 06:30 AM |
| LAMATTINA JOHN L | Director | Jan 15, 2023 | Option Exercise | $4.00 | 15,125 | 60,500 | 66,953 | Jan 17, 2023, 06:29 AM |
| Lefenfeld Michael | Director | Jan 15, 2023 | Option Exercise | $4.00 | 13,875 | 55,500 | 40,747 | Jan 17, 2023, 06:28 AM |
| RAPP MICHAEL | Director | Jan 15, 2023 | Option Exercise | $4.00 | 17,500 | 70,000 | 817,366 | Jan 17, 2023, 06:26 AM |
| RAPP MICHAEL | Director | Sep 13, 2021 | Buy | $19.96 | 25,962 | 518,201 | 208,742 | Sep 14, 2021, 07:28 AM |
| RAPP MICHAEL | Director | Sep 09, 2021 | Buy | $18.19 | 30,450 | 553,774 | 167,280 | Sep 13, 2021, 07:52 AM |
| RAPP MICHAEL | Director | Sep 10, 2021 | Buy | $17.85 | 15,500 | 276,675 | 182,780 | Sep 13, 2021, 07:52 AM |
| BARON RICHARD A | Director | Aug 18, 2021 | Option Exercise | $11.38 | 2,343 | 26,663 | 2,343 | Aug 20, 2021, 06:25 PM |
| Lefenfeld Michael | Director | May 25, 2021 | Buy | $18.44 | 2,715 | 50,065 | 25,537 | May 26, 2021, 09:32 PM |
| Lefenfeld Michael | Director | May 24, 2021 | Buy | $17.80 | 600 | 10,680 | 22,822 | May 26, 2021, 09:32 PM |
| Lefenfeld Michael | Director | May 26, 2021 | Buy | $19.03 | 1,335 | 25,405 | 26,872 | May 26, 2021, 09:32 PM |
| RAPP MICHAEL | Director | May 26, 2021 | Buy | $18.94 | 2,300 | 43,562 | 136,830 | May 26, 2021, 09:31 PM |
| RAPP MICHAEL | Director | May 25, 2021 | Buy | $18.32 | 19,303 | 353,631 | 134,530 | May 26, 2021, 09:31 PM |
| RAPP MICHAEL | Director | May 24, 2021 | Buy | $18.38 | 31,895 | 586,230 | 115,227 | May 26, 2021, 09:31 PM |
| RAPP MICHAEL | Director | Oct 06, 2020 | Buy | $12.00 | 83,332 | 999,984 | 638,886 | Oct 08, 2020, 06:16 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
| Owner | Relationship | Date | Value($) |
| SIEGALL CLAY B | President and CEO | 10/02/2023 | 999,996 |
| Turner Bruce | Chief Strategy Officer | 10/02/2023 | 249,993 |
| RAPP MICHAEL | Director | 10/02/2023 | 1,499,993 |
| WAGENHEIM PHILIP | Director | 01/15/2023 | 35,000 |
| LAMATTINA JOHN L | Director | 01/15/2023 | 60,500 |
| Lefenfeld Michael | Director | 01/15/2023 | 55,500 |
| RAPP MICHAEL | Director | 01/15/2023 | 70,000 |
| RAPP MICHAEL | Director | 09/13/2021 | 518,201 |
| RAPP MICHAEL | Director | 09/09/2021 | 553,774 |
| RAPP MICHAEL | Director | 09/10/2021 | 276,675 |
| BARON RICHARD A | Director | 08/18/2021 | 26,663 |
| Lefenfeld Michael | Director | 05/25/2021 | 50,065 |
| Lefenfeld Michael | Director | 05/24/2021 | 10,680 |
| Lefenfeld Michael | Director | 05/26/2021 | 25,405 |
| RAPP MICHAEL | Director | 05/26/2021 | 43,562 |
| RAPP MICHAEL | Director | 05/25/2021 | 353,631 |
| RAPP MICHAEL | Director | 05/24/2021 | 586,230 |
| RAPP MICHAEL | Director | 10/06/2020 | 999,984 |
Load More Insider Transactions
FUNDS WITH A POSITION IN IMMUNOME INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 390,636 | 0.00011% | 818.52% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 320,838 | 0.00036% | 278.76% | Other |
| ALPINE GLOBAL MANAGEMENT, LLC | 192,333 | 0.66% | -47.45% | Event Driven |
| RENAISSANCE TECHNOLOGIES LLC | 121,500 | 0.00201% | 275% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 28,649 | 0.00058% | New | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR IMMUNOME INC
STOCK BUYBACKS FOR IMMUNOME INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2022
63.63%
5Q
06/30/2022
63.63%
6Q
03/31/2022
63.69%
7Q
12/31/2021
63.89%
8Q
09/30/2021
66.27%
9Q
06/30/2021
73.20%
10Q
03/31/2021
86.49%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR IMMUNOME INC
LOADING...